A Crossover Study to Evaluate the Relative Bioavailability of Two Formulations of Deuterated Remdesivir Hydrobromide for Oral Suspension in Healthy Chinese Adults

NCT07510529 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

48

Enrollment

OTHER

Sponsor class

Conditions

Healthy Participants

Interventions

DRUG: T-R (Test-Reference drug)
DRUG: R-T (Reference-Test drug)

Sponsor

Simcere Pharmaceutical Co., Ltd